Citation Impact
Citing Papers
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation
2014
Two‐Time Window and Multiangle Photon Correlation Spectroscopy Size and Zeta Potential Analysis — Highly Sensitive Rapid Assay for Dispersion Stability
2000
Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs
1998
Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging
2004
Nano-sized MRI contrast agents with dendrimer cores
2005
Preoperative Breast Cancer Staging: MR Imaging of the Axilla with Ultrasmall Superparamagnetic Iron Oxide Enhancement
2002
Surface properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil
1995
Imaging in the era of molecular oncology
2008 StandoutNature
First‐pass contrast‐enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)‐based blood pool agent
2004
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent
2006
Electron microscopy study of intrahepatic ultrasmall superparamagnetic iron oxide kinetics in the rat. Relation with magnetic resonance imaging
1999
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil
1995
The Catabolic Fate of Nitric Oxide
2002
Magnetic Resonance Angiography With Gadomer-17
1998
Monomer-Coated Very Small Superparamagnetic Iron Oxide Particles as Contrast Medium for Magnetic Resonance Imaging
2002
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
1998
Axillary lymph node metastases: A statistical analysis of various parameters in MRI with USPIO
2002
In vivo MRI of brain inflammation in human ischaemic stroke
2004
Detection of lymph node metastases by contrast‐enhanced MRI in an experimental model
2002
MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agent
2000
Post‐Crystal Engineering of Zinc‐Substituted Myoglobin to Construct a Long‐Lived Photoinduced Charge‐Separation System
2011 StandoutNobel
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Solvent-free atom transfer radical polymerization for the preparation of poly(poly(ethyleneglycol) monomethacrylate)-grafted Fe3O4 nanoparticles: Synthesis, characterization and cellular uptake
2007
Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10–enhanced MR Imaging: Phase III Safety and Efficacy Study
2003
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Imaging of the lymphatic system: new horizons
2006
A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The In Vivo Behaviour
2002
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
The golden age: gold nanoparticles for biomedicine
2011 Standout
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
2006
Site-Specific Conjugation of a Temperature-Sensitive Polymer to a Genetically Engineered Protein
1994
In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
1999
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis
2005
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Nanotechnology: Intelligent Design to Treat Complex Disease
2006
Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model
2001
A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection
2000
NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography
2000
A review of performance of near-infrared fluorescence imaging devices used in clinical studies
2014
A novel method to prepare water‐dispersible magnetic nanoparticles and their biomedical applications: Magnetic capture probe and specific cellular uptake
2008
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
2004
Magnetic resonance relaxation properties of superparamagnetic particles
2009
Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition
2009
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
2003
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging
2001
Clearance of Iron Oxide Particles in Rat Liver
2006
Recent advances in iron oxide nanocrystal technology for medical imaging☆
2006
A Nanoparticle Size Series for In Vivo Fluorescence Imaging
2010 StandoutNobel
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Superparamagnetic Iron Oxide–enhanced MR Imaging of Head and Neck Lymph Nodes
2002
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Clinical imaging of cancer metastasis
2000
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Enhanced peroxidase activity and tumour tissue visualization by cobalt-doped magnetoferritin nanoparticles
2016
Dual Stimulus Switching of a [2]Catenane in Water
2011 StandoutNobel
Important Considerations in the Design of Iron Oxide Nanoparticles as Contrast Agents for Tl-Weighted MRI and MRA
2002
Effect of homocysteine‐lowering treatment with folic acid plus vitamin B6 on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo‐controlled, randomized trial
2004
Three Types of Physical Measurements Needed to Characterize Iron Oxide Nanoparticles for MRI and MRA
2002
Prospects of Colloidal Nanocrystals for Electronic and Optoelectronic Applications
2009 Standout
Toxic Potential of Materials at the Nanolevel
2006 StandoutScience
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
A Water-Soluble pH-Triggered Molecular Switch
2013 StandoutNobel
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats
2008 Standout
Long-circulating iron oxides for MR imaging
1995
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
2016 Standout
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
1999 Standout
Silica- and Alkoxysilane-Coated Ultrasmall Superparamagnetic Iron Oxide Particles: A Promising Tool To Label Cells for Magnetic Resonance Imaging
2006
Superparamagnetic Iron Oxide Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy
2013
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Water as an Active Constituent in Cell Biology
2007 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran
2005
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
2001
Amplification of One-Bond 1H/2H Isotope Effects on 15N Chemical Shifts in Clostridium pasteurianum Rubredoxin by Fermi-Contact Effects through Hydrogen Bonds
1998
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
2002
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
Ferumoxtran-10-Enhanced MR Lymphangiography: Does Contrast-Enhanced Imaging Alone Suffice for Accurate Lymph Node Characterization?
2005
Models of the Cytochromes. Redox Properties and Thermodynamic Stabilities of Complexes of “Hindered” Iron(III) and Iron(II) Tetraphenylporphyrinates with Substituted Pyridines and Imidazoles
1996
Imaging Characteristics of Zinc Sulfide Shell, Cadmium Telluride Core Quantum Dots
2008
The Molecular Mechanism of Autoxidation for Myoglobin and Hemoglobin: A Venerable Puzzle
1998
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles
2003
Tuning Charge-State Localization in a Semiconductive Iron(III)–Chloranilate Framework Magnet Using a Redox-Active Cation
2020 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent
2006
Syntheses and Dynamics of Donor−Acceptor [2]Catenanes in Water
2010 StandoutNobel
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents.
2007
In Vivo Detection of Macrophages in Human Carotid Atheroma
2004
TARGETED CONTRAST AGENTS IN MR IMAGING
1996
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Preparation of ultrafine silica- and PEG-coated magnetite particles
2001
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized Nanoparticles
2010 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Synthesis, X-ray Structural Determination, and Magnetic Susceptibility, Mössbauer, and EPR Studies of (Ph4P)2[Fe2(Cat)4(H2O)2]·6H2O, a Catecholato-Bridged Dimer of Iron(III)
1996
Dynamic Docking and Electron-Transfer between Cytochrome b5 and a Suite of Myoglobin Surface-Charge Mutants. Introduction of a Functional-Docking Algorithm for Protein−Protein Complexes
2004
Clearance Pathways and Tumor Targeting of Imaging Nanoparticles
2015
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
2015
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
2009
Design of Novel Inorganic−Organic Hybrid Materials Based on Iron-Chloranilate Mononuclear Complexes: Characteristics of Hydrogen-Bond-Supported Layers toward the Intercalation of Guests
2002 StandoutNobel
NMR scalar couplings across Watson–Crick base pair hydrogen bonds in DNA observed by transverse relaxation-optimized spectroscopy
1998 StandoutNobel
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Macrophage Accumulation Associated With Rat Cardiac Allograft Rejection Detected by Magnetic Resonance Imaging With Ultrasmall Superparamagnetic Iron Oxide Particles
2001
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Clinical Translation of Nanomedicine
2015
Surface molecular recognition
2001 StandoutNobel
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of Stuart J. McLachlan being referenced
Ultrasmall Superparamagnetic Iron Oxide to Enhance MRA of the Renal and Coronary Arteries: Studies in Human Patients
1996
Preliminary clinical experience with AMI 227
1996
Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.
1994
Hydrogen isotope effects on the proton nuclear magnetic resonance spectrum of bovine ferricytochrome b5: Axial hydrogen bonding involving the axial His-39 imidazole ligand
1994
Phase I clinical evaluation of a new iron oxide MR contrast agent
1994
AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.
1994
MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent
1997
Characterization of Reactive Versus Tumor-Bearing Lymph Nodes with Interstitial Magnetic Resonance Lymphography in an Animal Model
1995
Diagnosis of carotid artery stenosis: comparison of 2DFT time-of-flight MR angiography with contrast angiography in 50 patients.
1991
Relationship between heme binding site structure and heme orientations of two ferrocytochrome b5s. A study in prosthetic group recognition
1990
Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
1994
The reaction of 1,1′-biphenyl-2,2′-dial with iron(III ) and the crystal structure of piperidinium bis[µ-(1,1′-biphenyl-2,2′-diolato-O,µ-O′)(1,1′-biphenyl-2,2′-diolato-O,O′)ferrate(III )]–ethanol(½)
1983
Pharmacokinetic Behavior of Gadoteridol Injection
1992
1H-NMR assignments and the dynamics of interconversion of the isomeric forms of cytochrome b5 in solution
1986
Ferricytochrome b5: assignment of heme propionate resonances on the basis of nuclear Overhauser effect measurements and the nature of interprotein contacts with partner redox proteins
1986
Myoglobin: cytochrome b5 interactions and the kinetic mechanism of metmyoglobin reductase.
1985